Cristina Harmelink
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cristina Harmelink has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Nikolaos Barkas
Broad Institute of Harvard and MIT, Cambridge, USA
2 shared publications - Rebecca J. Oakey
King's College London
2 shared publications - Bertille Montibus
Genetics, Reproduction and Development Institute (iGReD), CNRS, INSERM, Clermont Auvergne University, Clermont-Ferrand, France
1 shared publication - Christina M. Reumiller
School of Cardiovascular and Metabolic Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence , James Black Centre,125 Coldharbour Lane, SE5 9NU London
1 shared publication George A. Malim
1 shared publication- Georgina Ellison-Hughes
Centre for Human and Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King’s College London , London
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
Zfpm1 regulates endothelial-mesenchymal transition and endocardial cell differentiation
The endocardium is the endothelial component of the heart that forms valves. Endocardial (EC) cells undergo endothelial-mesenchymal transition which distinguishes them from endothelial (ET) cells, despite sharing markers and a mesodermal origin. Nfatc1, uniquely labels EC cells but is not sufficient for EC cell specification, since knockouts form valves, albeit underdeveloped, therefore the regulators that specify EC fate remain incompletely defined. Using an in vivo Nfatc1 reporter system, we show that EC and ET cells are transcriptionally distinct and identify the transcription factor Zfpm1 (Fog1), as a regulator of EC cell specification. In an in vitro embryonic stem cell differentiation model Zfpm1 knockdown impairs EC cell differentiation, reduces endothelial- mesenchymal transition and alters contractility and beating phenotype, consistent with reduced differentiation of EC cells affecting the crosstalk with myocardial cells. These findings are consistent with data linking mutations in the human ZFPM1 gene with non-syndromic tetralogy of Fallot. This and the broad expression pattern across all regions of the cardiac outflow tract support a novel role for Zfpm1 in mammalian EC cell differentiation and endothelial-mesenchymal transition. This study extends the in vivo evidence of its importance during cardiac development and provides new insights into the transcriptional control of EC lineages.
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessZfpm1 regulates endothelial-mesenchymal transition and endocardial cell differentiation
The endocardium is the endothelial component of the heart that forms valves. Endocardial (EC) cells undergo endothelial-mesenchymal transition which distinguishes them from endothelial (ET) cells, despite sharing markers and a mesodermal origin. Nfatc1, uniquely labels EC cells but is not sufficient for EC cell specification, since knockouts form valves, albeit underdeveloped, therefore the regulators that specify EC fate remain incompletely defined. Using an in vivo Nfatc1 reporter system, we show that EC and ET cells are transcriptionally distinct and identify the transcription factor Zfpm1 (Fog1), as a regulator of EC cell specification. In an in vitro embryonic stem cell differentiation model Zfpm1 knockdown impairs EC cell differentiation, reduces endothelial- mesenchymal transition and alters contractility and beating phenotype, consistent with reduced differentiation of EC cells affecting the crosstalk with myocardial cells. These findings are consistent with data linking mutations in the human ZFPM1 gene with non-syndromic tetralogy of Fallot. This and the broad expression pattern across all regions of the cardiac outflow tract support a novel role for Zfpm1 in mammalian EC cell differentiation and endothelial-mesenchymal transition. This study extends the in vivo evidence of its importance during cardiac development and provides new insights into the transcriptional control of EC lineages.
- Open Access
- 1 May 2019
- Published by The Company of Biologists in Development
- Vol. 146 (9)
Myocardial differentiation is dependent upon endocardial signaling during early cardiogenesis in vitro
The endocardium interacts with the myocardium to promote proliferation and morphogenesis during the later stages of heart development. However, the role of the endocardium in early cardiac ontogeny remains under-explored. Given the shared origin, subsequent juxtaposition, and essential cell-cell interactions of endocardial and myocardial cells throughout heart development, we hypothesized that paracrine signaling from the endocardium to the myocardium is crucial for initiating early differentiation of myocardial cells. To test this, we generated an in vitro, endocardial-specific ablation model using the diphtheria toxin receptor under the regulatory elements of the Nfatc1 genomic locus (NFATc1-DTR). Early treatment of NFATc1-DTR mouse embryoid bodies with diphtheria toxin efficiently ablated endocardial cells, which significantly attenuated the percentage of beating EBs in culture and expression of early and late myocardial differentiation markers. The addition of Bmp2 during endocardial ablation partially rescued myocyte differentiation, maturation and function. Therefore, we conclude that early stages of myocardial differentiation rely on endocardial paracrine signaling mediated in part by Bmp2. Our findings provide novel insight into early endocardial-myocardial interactions that can be explored to promote early myocardial development and growth.
- 1 May 2019
- Published by The Company of Biologists in Development
- Vol. 146 (9)
Open AccessMyocardial differentiation is dependent upon endocardial signaling during early cardiogenesis in vitro
The endocardium interacts with the myocardium to promote proliferation and morphogenesis during the later stages of heart development. However, the role of the endocardium in early cardiac ontogeny remains under-explored. Given the shared origin, subsequent juxtaposition, and essential cell-cell interactions of endocardial and myocardial cells throughout heart development, we hypothesized that paracrine signaling from the endocardium to the myocardium is crucial for initiating early differentiation of myocardial cells. To test this, we generated an in vitro, endocardial-specific ablation model using the diphtheria toxin receptor under the regulatory elements of the Nfatc1 genomic locus (NFATc1-DTR). Early treatment of NFATc1-DTR mouse embryoid bodies with diphtheria toxin efficiently ablated endocardial cells, which significantly attenuated the percentage of beating EBs in culture and expression of early and late myocardial differentiation markers. The addition of Bmp2 during endocardial ablation partially rescued myocyte differentiation, maturation and function. Therefore, we conclude that early stages of myocardial differentiation rely on endocardial paracrine signaling mediated in part by Bmp2. Our findings provide novel insight into early endocardial-myocardial interactions that can be explored to promote early myocardial development and growth.